Chemotherapy dose intensity
Chemotherapy dose intensity has been studied in 1 paper since 2023: 1 observational study in people. The newest paper, Apr 28, 2023: “Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma”.
1 paper studies it2 findingsUpdated
See all 1 papers on chemotherapy dose intensity
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Initial dose intensity (IDI) and relative dose intensity (RDI) had a significant impact on OS in fit patients.”
1 of its findings points the other way.
- 1 lab in 1 country
- 1 finding against
- Humans1
What did studies of chemotherapy dose intensity find?
1Studies of chemotherapy dose intensity measured one outcome, overall survival.
Overall survival
no changein humans1upin humans1
1 study
Overall survival
no changein humans1upin humans1
Chemotherapy dose intensity was not clearly linked with overall survival in non-fit (unfit and frail) elderly patients with DLBCL.
Humansin non-fit (unfit and frail) elderly patients with DLBCL
Chemotherapy dose intensity is linked with better overall survival in fit elderly patients with DLBCL.
Humansin fit elderly patients with DLBCL